A study published in Cell describes how long-term registry data allowed them to analyse outcomes among people with dementia who had received a specific vaccine.
The dataset created what several experts call a “natural experiment” because vaccinated and unvaccinated groups emerged organically rather than through assignment.
According to Medical News Today, individuals who received the vaccine showed slower cognitive decline and a lower risk of dementia-related death for nearly a decade.
Possible biological explanations
Why such an effect might occur remains uncertain.
Also read: Researchers identify overlooked factor contributing to high blood pressure
Dr. Zeeshan Khan, a geriatric specialist, said the findings align with theories suggesting that reduced neuroinflammation can help protect vulnerable nerve cells.
He noted that certain vaccines may help prevent dormant viruses in the nervous system from reactivating, an idea researchers have explored in previous vaccine, dementia studies.
These mechanisms are still debated, but they underline how challenging it is to identify interventions that meaningfully alter dementia trajectories.
What researchers still don’t know
Neuropsychologist Raphael Wald said that the study design provides stronger evidence than many observational analyses because the groups were naturally separated by vaccination status.
Also read: Eating eggs may slow cognitive decline in older adults
Although, the Cell authors caution that registry studies cannot replace controlled clinical trials.
Similar patterns have appeared with other routine vaccines, which they say makes the topic worthy of deeper investigation.
Still, determining whether vaccination can be used strategically for dementia prevention or disease modification will require much more targeted research.
Sources: Medical News Today, and Cell.
Also read: Study reveals how rosemary may support scar-free healing
Also read: Researchers: Garlic mouthwash can match dentistry’s strongest standard